Medicare Enrolled

Dr. Avinash Chenam, M.D.

Urology Physician · San Bernardino, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
489 E 21ST ST, San Bernardino, CA 92404
9098822973
In practice since 2010 (15 years)
NPI: 1841502986 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chenam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chenam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chenam

Dr. Avinash Chenam is an urology physician in San Bernardino, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Chenam performed 629 Medicare services across 425 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chenam received a total of $72,176 from 53 pharmaceutical and/or device companies across 363 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chenam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ 629 Medicare services $72,176 industry payments

Medicare Practice Summary

Medicare Utilization ↗
629
Medicare services
Bottom 33% in CA for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
425
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~42 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
173 $67 $136
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
113 $91 $178
Leuprolide acetate (for depot suspension), 7.5 mg 85 $127 $648
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
51 $8 $120
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
43 $137 $330
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
42 $46 $166
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
39 $128 $277
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
36 $28 $48
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
24 $189 $390
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
12 $93 $256
Suture suspension of urethra to control leakage using an endoscope
A surgical procedure that uses an endoscope to place sutures that suspend the urethra in order to control urinary leakage.
11 $229 $938
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$72,176
Total received (2018-2024)
Avg $10,311/year across 7 years
Top 5% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
363
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$56,707 (78.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,469 (21.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$24,279
2023
$35,719
2022
$4,269
2021
$1,334
2020
$945
2019
$2,168
2018
$3,462

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$21,734
PROCEPT BioRobotics Corporation
$1,088
BIOTISSUE HOLDINGS INC.
$706
Dendreon Pharmaceuticals LLC
$164
ABBVIE INC.
$104
Bayer Healthcare Pharmaceuticals Inc.
$101
Tolmar, Inc.
$98
Sumitomo Pharma America, Inc.
$85
Novartis Pharmaceuticals Corporation
$53
Janssen Biotech, Inc.
$45
Axonics, Inc.
$36
Astellas Pharma US Inc
$25
PFIZER INC.
$24
Baxter Healthcare
$15
Top 3 companies account for 96.9% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$41,316
INTUITIVE SURGICAL, INC.
$21,734
Boston Scientific Corporation
$1,561
PROCEPT BioRobotics Corporation
$1,088
BIOTISSUE HOLDINGS INC.
$706
Astellas Pharma US Inc
$460
PFIZER INC.
$440
Dendreon Pharmaceuticals LLC
$364
TOLMAR Pharmaceuticals, Inc.
$322
AbbVie Inc.
$310
ABBVIE INC.
$279
Sumitomo Pharma America, Inc.
$271
Medtronic USA, Inc.
$263
Myovant Sciences Inc.
$253
BioTissue Holdings, Inc.
$221
BIOTISSUE HOLDINGS, INC.
$205
Janssen Biotech, Inc.
$204
Tolmar, Inc.
$145
Teleflex LLC
$143
Bayer Healthcare Pharmaceuticals Inc.
$141
TISSUETECH, INC.
$139
Cook Incorporated
$131
BOSTON SCIENTIFIC CORPORATION
$125
Davol Inc.
$120
Coloplast Corp
$115
Blue Earth Diagnostics Limited
$108
Bayer HealthCare Pharmaceuticals Inc.
$86
Agiliti Health, Inc.
$85
Olympus America Inc.
$82
Baxter Healthcare
$79
COLOPLAST CORP
$73
AbbVie, Inc.
$71
Novartis Pharmaceuticals Corporation
$53
NeoTract Inc.
$51
Photocure Inc
$44
Laborie Medical Technologies Corp.
$39
C. R. Bard, Inc. & Subsidiaries
$36
Axonics, Inc.
$36
Hollister Incorporated
$29
Sun Pharmaceutical Industries Inc.
$26
Foundation Medicine, Inc.
$26
Integra LifeSciences Corporation
$23
UroGen Pharma, Inc.
$23
UROVANT SCIENCES INC
$20
ConvaTec Inc.
$20
Retrophin, Inc.
$18
Ferring Pharmaceuticals Inc.
$17
Avadel Specialty Pharmaceuticals, LLC
$16
Antares Pharma, Inc.
$14
Merck Sharp & Dohme LLC
$13
Ethicon US, LLC
$12
UROGEN PHARMA, INC.
$12
Myriad Genetic Laboratories, Inc.
$12
Top 3 companies account for 89.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADVANCE · AMS · AQUABEAM SYSTEM · ARISTA AH FlexiTip · Axonics · Axumin · BIOFIX · BOTOX · Bard Urinary Drainage Bag · CONTINENCE CARE · COOK MEDICAL ACCESSORIES · COOK MEDICAL INCONTINENCE · COOK MEDICAL PERC SETS · Cysview · DAVINCI XI · Da Vinci Surgical System · ELIGARD · ERLEADA · FIRMAGON · FOUNDATIONONE · FOUNDATIONONE CDX · GEMTESA · GENERAL BPH · GENERAL - KIDNEY STONE DISEASE · GENTLECATH · INTERSTIM · JELMYTO · KEYTRUDA · LITHOVUE · LITHOVUE EMPOWER · LUPRON DEPOT · Lupron · Lupron Depot · Myrbetriq · NEOX · NOCDURNA · Noctiva · Nubeqa · ONLI · ORGOVYX · Olympus Cysto-Resection · PLUVICTO · POSLUMA · PROVENGE · Prolaris · REZUM · STRATAFIX · SpeediCath · TISSEEL · TOVIAZ · UROLIFT · UroLift · UroLift System · VAPRO · XTANDI · Xofigo · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for urology physician in CA.

Looking for an urology physician in San Bernardino?
Compare urology physicians in the San Bernardino area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
65
Per 100K population
3.0
County median income
$82,184
Nearest hospital
ST BERNARDINE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chenam is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of CA peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chenam experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Chenam performed 173 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chenam receive payments from pharmaceutical companies?
Yes. Dr. Chenam received a total of $72,176 from 53 companies across 363 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chenam's costs compare to other urology physicians in San Bernardino?
Dr. Chenam's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chenam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →